Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome

Journal of the Neurological Sciences

Volumn 270, Issue 1-2, 2008, Pages 194-196

  Lorenzoni, Paulo J ^a   Scola, Rosana H ^a   Lang, Bethan ^b   Kay, Claudia S K ^a   Teive, Helio A G ^a   Kowacs, Pedro A ^a   Werneck, Lineu C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cerebellar ataxia; Compound muscle action potencial; Electrophysiological study; Lambert Eaton myasthenic syndrome; P Q type voltage gated calcium channel antibody; Repetitive stimulation

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; LEVOTHYROXINE; PREDNISONE; PYRIDOSTIGMINE; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID; DIZZINESS; DYSARTHRIA; EATON LAMBERT SYNDROME; ELECTROPHYSIOLOGY; FEMALE; GAIT DISORDER; HUMAN; HYPOTHYROIDISM; LEG; MALE; MOTOR DYSFUNCTION; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE TONE; MUSCLE WEAKNESS; NYSTAGMUS; PRIORITY JOURNAL; PTOSIS; SERUM; TENDON REFLEX; XEROSTOMIA;

ACTION POTENTIALS; ADULT; ANTIBODIES; CALCIUM CHANNELS; CEREBELLAR ATAXIA; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEURAL CONDUCTION; PARANEOPLASTIC SYNDROMES;

EID: 44649166352     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.02.004     Document Type: Article

References (12)

1. Fukuda T., Motomura M., Nakao Y., Shiraishi H., Yoshimura T., Iwanaga K., et al. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53 (2003) 21-28
2. Newsom-Davis J. Neuromuscular junction channelopathies: a brief overview. Acta Neurol. Belg. 105 (2005) 181-186
3. Maddison P., Lang B., Mills K., and Newsom-Davis J. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry 70 (2001) 212-217
4. Motomura M. The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases. Rinsho Shinkeigatu 39 (1999) 1237-1239
5. Nakao Y.K., Motomura M., Fukudome T., Fukuda T., Shiraishi H., Yoshimura T., et al. Seronegative Lambert-Eaton myasthenic syndrome: study of 110 japanese patients. Neurology 59 (2002) 1773-1775
6. Eaton L.M., and Lambert E.H. Electromyography and electric stimulation of nerves in diseases of the motor unit. JAMA 163 (1957) 1117-1124
7. Graus F., Lang B., Pozo-Rosich P., Saiz A., and Casamitjana R. Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59 (2002) 764-766
8. Mason W.P., Graus F., Lang B., Honnorat J., Delattre J.Y., Valldeoriola F., et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120 (1997) 1279-1300
9. Pinto A., Gillard S., Moss F., Whyte K., Brust P., Williams M., et al. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci USA 95 (1998) 8328-8333
10. Fletcher C.F., and Lennon V.A. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?. Ann Neurol 53 (2002) 5-7
11. 2+ flux in a human small cel carcinoma line. Nature 317 (1985) 737-739
12. Blumenfeld A.M., Recht L.D., Chad D.A., DeGirolami U., Griffin T., and Jaeckle K.A. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 41 (1991) 1682-1685